Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.
Recent Publications
Kiripolsky, J, Kaperek, EM, Zhu, C, Li, QZ, Wang, J, Yu, G, Kramer J. Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary Sjögren‘s syndrome. Journal of Autoimmunity. 2021; 118
Leigh LY, Vannelli P, Crow HC, Desai S, Lepore M, Anolik R, Glick M. Diseases of the Respiratory Tract. 2021
Carrasco-Labra A, Tampi M, Urquhart O, Howell S, Booth HA, Glick M. How to Identify, Interpret and Apply the Scientific Literature to Practice. 2021
Glick M, Greenberg MS, Lockhart PB, Challacombe S. Burket’s Oral Medicine. 13th Edition. 2021
Ursomanno B.L., Cohen R.E., Levine M.J., and Yerke L.M.:. Effect of hypothyroidism on bone loss at dental implants.. Journal of Oral Implantology. 2021
Mark K Farrugia , Sung Jun Ma , Mark W Hennon , Chukwumere E Nwogu , Elisabeth U Dexter , Anthony L Picone , Todd L Demmy , Jorge A Gomez-Suescun , Simon Fung-Kee-Fung , Sai S Yendamuri , Anurag K Singh. Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis. American Journal of Clinical Oncology. 2021
Martone G, Thomas RD, Keuchle J, Abdul Aziz R. Isolated Facet Joint Arthritis in Juvenile Idiopathic Arthritis. Cureus. 2021; 13(1)
Collaborative Research: Control of Information Processing and Learning in Neuronal Networks through Light-mediated Programming of Genomic Networks. Yongho Bae (Co-Principal Investigator). National Science Foundation. $599,488. 2/1/2021-1/1/2024.
Mapping of Antibodies Derived from Plasmablasts during Kawasaki Disease. Mark Hicar (Principal Investigator). Wildermuth Memorial Foundation. $25,000. 1/1/2021-12/1/2021.
Optimal Arm-Bed Angle for Delivering Effective Chest Compressions. Jayasree Nair (Principal Investigator). Wildermuth Memorial Foundation. $7,500. 1/1/2021-12/1/2021.
School Attendance for Children with Type 1 Diabetes during the COVID Pandemic. Kathleen Bethin (Co-Principal Investigator), Lucy Mastrandrea (Co-Principal Investigator). Wildermuth Memorial Foundation. $6,700. 1/1/2021-12/1/2021.
Optimal Inspired Oxygen during Chest Compressions in Neonatal Resuscitation. Munmun Rawat (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $159,500. 1/1/2021-12/1/2022.
Expanding the toolkit for design of robust phage therapeutic cocktails. Anne Kathryn Kauffman (Principal Investigator), Frank Scannapieco (Co-Investigator). NIH. $438,625. 12/1/2020-11/1/2022.
Environmental Health Scholar. Sarah Ventre (Principal Investigator). New York State Children’s Environmental Health Center. 11/1/2020-11/1/2022.
The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease (COPD). Manoj Mammen (Co-Investigator). Department of Defense, U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs. $1,057,527. 10/1/2020-8/1/2022.
Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
MTM 2: Collaborative Research: How does phage life history strategy govern predation in microbiomes?. Anne Kathryn Kauffman (Co-Investigator). NSF. $848,751. 9/1/2020-8/1/2025.
Impact of Advanced Therapy on Mental Health in Cystic Fibrosis (CF). Carla Frederick (Co-Investigator), Danielle Goetz (Co-Investigator). University at Buffalo Office of Research and Economic Development. $25,000. 9/1/2020-8/1/2021.
Evaluating Determinants of PK, Tissue Distribution, and Efficacy of siRNA-antibody Conjugates. Sukyung Woo (Principal Investigator). Center for Protein Therapeutics. $100,000. 9/1/2020-8/1/2021.
Planning for NIA R21/R33 Grant- Patient Driven Deprescribing to Enhance Successful Aging. Collin Clark (Co-Investigator), Christopher Daly (Co-Investigator), David Jacobs (Co-Investigator), Scott Monte (Co-Investigator), Ranjit Singh (Co-Principal Investigator), Robert Wahler (Co-Principal Investigator). US Deprescribing Research Network. $60,000. 8/1/2020-7/1/2021.
Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae. Thomas Russo (Principal Investigator). NIH. $431,682. 8/1/2020-7/1/2022.
